Board Game Project for Adolescents With Tourette Syndrome

September 30, 2022 updated by: Mei-Yin Lee, National Taipei University of Nursing and Health Sciences

Study on the Effectiveness of an Evidence-based Board Game Project to Help Improve Tics and Interpersonal Interactions of Adolescents With Tourette Syndrome: Mixed Methods Research

The purpose of this research is to investigate the effectiveness of using an evidence-based board game scheme to improve the tics and interpersonal interactions of adolescents with Tourette syndrome.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study utilizes a randomized control study design. According to the situated learning theory and qualitative research findings, this study develops a board game scheme. This study enrolled adolescents with Tourette syndrome the age of 12 to 20 and their parents as the subjects. The implementation process of this study is to implement a board game workshop once for the experimental group so as to make sure that the subjects understood the rules of a board game. The subjects played the board game at least once at home every week. The 60 minutes parent-child co-learning board game was played for 4 consecutive weeks. On the contrary, the control group continued to receive health education instructions at the outpatient clinic. The research team employs both qualitative and quantitative methods to evaluate the effectiveness and experiences after the subjects underwent the learning scheme. The quantitative effectiveness indicators include self-reported severity of tics of adolescents, depression, positive mental health, and social adjustment. Moreover, this study performed qualitative interviews with parents to understand their parent-child interactive experiences after playing the board game. The researcher believes that this study can help improve the tics of adolescents with Tourette syndrome, as well as enhance their interpersonal interactions and relationships.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. adolescents between the ages of 12 and 20 years were diagnosed with Tourette Syndrome by a pediatrician according to the DSM IV.
  2. ability to speak and understand Mandarin.
  3. adolescents and their parents were willing to participate and fill in consent forms.

Exclusion Criteria:

(1) Adolescents with Tourette Syndrome have mental illness and serious diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The participants played the board game at least once at home every week. In addition, the 60 minutes parent-child co-learning board game was played for 4 consecutive weeks.
Behavioral: board game
A board game was designed based on situated learning theory and the results of relevant studies. This board game contains a summary, answer booklet, and multiple card game tasks including situations of interpersonal interaction. The participants must discuss, share personal experiences, and find the answer together.
Other Names:
  • Non
No Intervention: Control group
The control group continued to receive health education instructions at the outpatient clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Yale Global Tic Severity Scale
Time Frame: Change from baseline tic severity at 1 month and 3 months
The Yale Global Tic Severity Scale will used in this research to evaluate adolescents' tic severity. The Yale Global Tic Severity Scale has a total score ranging from 0 to 100, with the high score indicating a higher tics severity.
Change from baseline tic severity at 1 month and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chinese Version Beck Youth Inventories (subscale-depression)
Time Frame: Change from baseline degree of depression at 1 month and 3 months
The Chinese Version Beck Youth Inventories (subscale-depression) will used in this research to evaluate adolescents' depression. The Chinese Version Beck Youth Inventories (subscale-depression) has a total score ranging from 20 to 80, with the high score indicating a higher depression.
Change from baseline degree of depression at 1 month and 3 months
Social adjustment scale for adolescents with Tourette syndrome
Time Frame: Change from baseline degree of social adjustment at 1 month and 3 months.
The Social adjustment scale for adolescents with Tourette Syndrome will used in this study to evaluate adolescents' degree of self-adjustment in social interactions. The lowest and highest total scores were 17 and 68, respectively. A high score indicates favorable social adjustment.
Change from baseline degree of social adjustment at 1 month and 3 months.
Positive Mental Health Scale
Time Frame: Change from baseline degree of positive mental health at 1 month and 3 months
TThe Positive Mental Health Scale will used in this study to evaluate adolescents' degree of positive mental health. The lowest and highest total scores were 25 and 125, respectively. A high score indicates favorable positive mental health.
Change from baseline degree of positive mental health at 1 month and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taipei University of Nursing and Health Sciences

Collaborators

Ministry of Science and Technology, Taiwan
Chang Gung Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Anticipated)

September 1, 2024

Study Completion (Anticipated)

September 1, 2024

Study Registration Dates

First Submitted

September 27, 2022

First Submitted That Met QC Criteria

September 30, 2022

First Posted (Actual)

October 4, 2022

Study Record Updates

Last Update Posted (Actual)

October 4, 2022

Last Update Submitted That Met QC Criteria

September 30, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201801998B0C501

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on board game

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe